Answer
Glyxambi’s active ingredients empagliflozin and linagliptin reach peak plasma concentrations at a median of 1.5 hours after oral dosing (linagliptin studied at 5 mg); a high-fat meal delays linagliptin’s peak by 2 hours, although this is not considered clinically relevant.
Sources for this answer
- Glyxambi 10 mg/5 mg film-coated tablets and Glyxambi 25 mg/5 mg film-coated tabletsBoehringer Ingelheim Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 14Document updated
Sources checked